Not from Aurora Health Care? Click the title link for additional options to access full-text. For best viewing, we recommend Google Chrome.

Works from 2018

Link

Androgen deprivation therapy for prostate cancer and incident atrial fibrillation, Zuber S. Ali, Tadele Mengesha, Suhail Allaqaband, and Arshad Jahangir (Poster)

Link

Blastic plasmacytoid dendritic cell neoplasm (BPDCN) on social media: #BPDCN-increasing exposure over two years since inception of a disease-specific twitter community, Naveen Pemmaraju, Audun Utengen, Vikas Gupta, Michael A. Thompson, and Andrew A Lane (Article)

Link

BRD4 inhibition Is synthetic lethal with PARP inhibitors through the induction of homologous recombination deficiency, Chaoyang Sun, Jun Yin, Yong Fang, Jian Chen, Kang Jin Jeong, Xiaohua Chen, Christopher P Vellano, Zhenlin Ju, Wei Zhao, Dong Zhang, Yiling Lu, Funda Meric-Bernstam, Timothy A Yap, Maureen Hattersley, Mark J O'Connor, Huawei Chen, Stephen Fawell, Shiaw-Yih Lin, Guang Peng, and Gordon B Mills (Article)

Link

Can we improve nonmuscle invasive bladder cancer guideline adherence with smarter risk stratification?, Tracy M Downs, John Weissert, and Kourosh Ravvaz (Article)

Link

C-reactive protein in HPV-positive and HPV-negative oropharyngeal cancer, Stephanie Johnson-Obaseki, Lisa Caulley, Martin Corsten, Geoffrey Liu, Jim Dimitroulakos, David Goldstein, Jonathan Irish, and Jennifer Rider (Article)

Link

Decreased trend in hospital mortality from pancreatic cancer despite increase in number of hospital admissions, Sanjay Bhandari, Mubeen Khan Mohammed Abdul, Will Hollabaugh, Kanav Sharma, Douglas B Evans, and Nalini M Guda (Article)

Link

Differential regulation of human monocytes and NK cells by antibody-opsonized tumors, Jun Yin, Alex J. Albers, Thomas S. Smith, Geoffrey T. Riddell, and John O. Richards (Article)

Factors influencing first-line therapy of acute myeloid leukemia (AML) patients (pts) in the Connect MDS/AML Disease Registry, Christopher R Cogle, Michael A. Thompson, and et al (Abstract)

Link

Follicular dendritic cell sarcoma with indolent T-lymphoblastic proliferation is associated with paraneoplastic autoimmune multiorgan syndrome, Matthew Walters, Mark R Pittelkow, Robert P Hasserjian, Nancy Lee Harris, William R Macon, Paul J Kurtin, and Karen L G Rech (Article)

Identification, prioritization, and treatment of mutations identified by next-generation sequencing, Aaron S Mansfield, Ben Ho Park, and Michael P. Mullane (Book Chapter)

Implementing precision medicine programs and clinical trials in the community-based oncology practice: barriers and best practices, Jennifer L Ersek, Lora J Black, Michael A. Thompson, and Edward S Kim (Book Chapter)

Implementing precision medicine programs and clinical trials in the community-based oncology practice: barriers and best practices, J L. Ersek, L J. Black, Michael A. Thompson, and E S. Kim (Book Chapter)

Link

MGMT inhibition in ER positive breast cancer leads to CDC2, TOP2A, AURKB, CDC20, KIF20A, Cyclin A2, Cyclin B2, Cyclin D1, ERα and survivin inhibition and enhances response to temozolomide, George C. Bobustuc, Amin B. Kassam, Richard Rovin, Sheila Jeudy, Joshua S Smith, Beth Isley, Maharaj Singh, Ameya Paranjpe, Kalkunte S Srivenugopal, and Santhi Konduri (Article)

Multidisciplinary management of oligometastatic soft tissue sarcoma, Juneko E Grilley-Olson, Nicholas P. Webber, David S. Demos, Jared D Christensen, and David G Kirsch (Book Chapter)

Link

One pulmonary lesion, 2 synchronous malignancies, Masooma Aqeel, Nevin Uysal-Biggs, Timothy S Fenske, and Nagarjun Rao (Article)

Link

Promoting team-based exercise among African American breast cancer survivors, Linda B Piacentine, Karen M Robinson, Leslie J. Waltke, Judy A. Tjoe, and Alexander V Ng (Article)

Link

Quantifying the effect of air gap, depth, and range shifter thickness on TPS dosimetric accuracy in superficial PBS proton therapy, Robert J. Shirey and Hsinshun Terry Wu (Article)

PDF

Racial Disparity Among Women Diagnosed With Invasive Breast Cancer in a Large Integrated Health System, Maharaj Singh, Santhi D. Konduri, George C. Bobustuc, Amin B. Kassam, and Richard A. Rovin (Original Research)

Reportable actionability versus pragmatic actionability: Implementing precision medicine at three large health systems, Michael A. Thompson, James Weese, Maharaj Singh, and et al (Abstract)

Link

Sentinel lymph node mapping in endometrioid endometrial cancer: does it work in the real world? [22A], Olga Valieva, Danielle M. Greer, Jessica J. Kram, Eric Schmit, Elizabeth L. Dickson, and Scott A. Kamelle (Abstract)

Link

Social media and clinical trials: The pros and cons gain context when the patient is at the center, Michael A. Thompson and Ruth M O'Regan (Article)

Successful automated normalization of cancer outcomes for half a million patients across four disparate health systems, Paul D. Tittel, Michael A. Thompson, James Weese, and et al (Abstract)

The effects of checkpoint blockade and a CD40 agonist on T-independent and T-dependent antibody responses in mice: implications for optimization of vaccination strategies in patients receiving immunotherapies, Karen Michel, Ashley Gehrand, Michael A. Thompson, and Martin Oaks (Article)

The effects of checkpoint blockade and a CD40 agonist on T-independent and T-dependent antibody responses in mice: implications for optimization of vaccination strategies in patients receiving immunotherapies, Karen Michel, Ashley Gehrand, Michael A. Thompson, and Martin Oaks (Article)

PDF

The Needs of Women Treated for Ovarian Cancer: Results From a #gyncsm Twitter Chat, Teresa Hagan Thomas, Karin Nauth-Shelley, Michael A. Thompson, Deanna J. Attai, Matthew S. Katz, David Graham, Dee Sparacio, Christina Lizaso, Audun Utengen, and Don S. Dizon (Original Research)

Link

The survival effect of repeat surgery at glioblastoma recurrence and its trend: a systematic review and meta-analysis, Victor M Lu, Toni R Jue, Kerrie L McDonald, and Richard A. Rovin (Article)

Works from 2017

Analysis of the use and impact of Twitter during American Society of Clinical Oncology annual meetings from 2011 to 2016: Focus on advanced metrics and user trends, Naveen Pemmaraju, Michael A. Thompson, Ruben A Mesa, and Tejas Desai (Article)

Best practices and practical nuances in the treatment of gastric cancer in high-risk global areas, Federico A. Sanchez (Article)

BRE12-158: A phase II randomized controlled trial of genomically directed therapy after preoperative chemotherapy in patients with triple negative breast cancer (TNBC), B Schneider, K D. Miller, S Badve, B O'Neil, P Helft, C Chitambar, C Falkson, R Nanda, M McCormick, M Danso, M Blaya, R Langdon, M Lippman, E Paplomata, R Walling, M Thompson, E Robin, L Aggarwal, I Shalaby, V Canfield, B Adesunloye, T Lee, K Daily, C Ma, J Erban, N Radhakrishnan, D Bruetman, M Graham, NA Reddy, FC Lynce, and M Radovich (Abstract)

Competitive funding strategies for the conquer cancer foundation of ASCO, Tanios Bekaii-Saab, Sanjay Goel, Adrien Dickerson, Jamie Von Roenn, Michael A. Thompson, and Anne S Tsao (Article)

PDF

Disulfram enhances Palbociclib and Abemaciclib activity through MGMT and CDK4/6 inhibition in breast cancer cells, Santhi Konduri, Deborah Donohoe, Dmitry Bosenko, Max Albiero, Tarun Jella, Olivia Fukui, Richard Rovin, Amin B. Kassam, and George C. Bobustuc (Poster)

Enhanced recovery program and length of stay after laparotomy on a gynecologic oncology service: A randomized controlled trial, Elizabeth L. Dickson, Erica Stockwell, Melissa A Geller, Rachel Isaksson Vogel, Sally A Mullany, Rahel Ghebre, Boris J N Witherhoff, Levi S Downs, Linda F Carson, Deanna Teoh, Michelle Glasgow, Matt Gerber, Colleen Rivard, Britt K Erickson, Jacob Hutchins, and Peter A Argenta (Article)

PDF

Generation of a Patient-Derived Brain Metastasis Breast Cancer Cell Line via Novel Orthotopic Injection Placement and Serial Mouse Transplantation to Develop PDX Mouse Model, Amber L. LaCrosse, Denise M. Coley, Paul J. Mintz, Santhi D. Konduri, Richard A. Rovin, and Amin B. Kassam (Supplement)

PDF

Multiple Myeloma Baseline Immunoglobulin G Level and Pneumococcal Vaccination Antibody Response, Michael A. Thompson, Martin K. Oaks, Maharaj Singh, Karen M. Michel, Michael P. Mullane, Husam S. Tarawneh, Angi Kraut, and Kayla J. Hamm (Brief Report)

PDF

Multiple Myeloma Vaccination Patterns in a Large Health System: A Pilot Study, Andinet Alemu, Maharaj Singh, Chris Blumberg, John O. Richards, Martin K. Oaks, and Michael A. Thompson (Original Research)

Phase 1b trial of proteasome inhibitor carfilzomib with irinotecan in lung cancer and other irinotecan-sensitive malignancies that have progressed on prior therapy (Onyx IST reference number: CAR-IST-553), Susanne M Arnold, Kari Chansky, Markos Leggas, Michael A. Thompson, John L Villano, John Hamm, Rachel E Sanborn, Glen J Weiss, Gurkamal Chatta, and Maria Q Baggstrom (Article)

Practice model for advanced practice providers in oncology, Jamie Cairo, Mary Ann Muzi, Deanna Ficke, Shaunta Ford-Pierce, Katrina Goetzke, Diane Stumvoll, Laurie Williams, and Federico A. Sanchez (Article)

Predicting nonmuscle invasive bladder cancer recurrence and progression in a United States population, Kourosh Ravvaz, Marcus E Walz, John Weissert, and Tracy M Downs (Article)

Reaffirming and Clarifying the American Society of Clinical Oncology's Policy Statement on the Critical Role of Phase I Trials in Cancer Research and Treatment, Jeffrey S Weber, Laura A Levit, Peter C Adamson, Suanna S Bruinooge, Howard A Burris, Michael A Carducci, Adam P Dicker, Mithat Gönen, Stephen M Keefe, Michael A Postow, Michael A Thompson, David M Waterhouse, Susan L Weiner, and Lynn M Schuchter (Article)

PDF

Robustness of a Newly Proposed Risk Schema for Lymphatic Dissemination in Endometrioid Endometrial Cancer, Danielle M. Greer, Jessica J.F. Kram, Callie M. Cox Bauer, and Scott A. Kamelle (Supplement)

PDF

Robustness of a newly proposed risk schema for lymphatic dissemination of endometrioid endometrial cancer, Danielle M. Greer, Jessica J F Kram, Callie M. Cox Bauer, and Scott A. Kamelle (Poster)

The emerging role of professional social media use in oncology, Mina S Sedrak, Don S Dizon, Patricia F Anderson, Michael J Fisch, David L Graham, Matthew S Katz, Jennifer C Kesselheim, Robert S Miller, Michael A. Thompson, Audun Utengen, and Deanna J Attai (Editorial)

Triathlon training for women breast cancer survivors: feasibility and initial efficacy, Alexander V Ng, Alyson N Cybulski, Ashley A Engel, Paula E Papanek, Megan A Sheffer, Leslie J. Waltke, and Judy A. Tjoe (Article)

Works from 2016

Abstract 2594: clinical pathways as a platform to support clinical research, Peter G. Ellis (Abstract)

Abstract 285: Disulfiram, a dual MGMT and aldehyde dehydrogenase inhibitor, sensitizes ER-positive breast cancer cells to temozolomide and cyclophosphamide, George C. Bobustuc, Deborah Donohoe, Alisher Holmuhamedov, Srivenugopal Kalkunte, and Santhi Konduri (Abstract)

Abstract S2-05: Event-free and overall survival following neoadjuvant weekly paclitaxel and dose-dense AC +/- carboplatin and/or bevacizumab in triple-negative breast cancer: outcomes from CALGB 40603 (Alliance), WM Sikov, DA Berry, CM Perou, B Singh, CT Cirrincione, SM Tolaney, G Somlo, ER Port, Rubina Qamar, K Sturtz, E Mamounas, M Golshan, JR Bellon, D Collyar, OM Hahn, LA Carey, CA Hudis, and EP Winer (Abstract)

Actionable biomarkers in a non-small cell lung cancer (NSCLC) clinical pathway (CP), Peter G. Ellis (Abstract)

Addressing administrative and regulatory burden in cancer clinical trials: Summary of a stakeholder survey and workshop hosted by the American Society of Clinical Oncology and the Association of American Cancer Institutes, Julie M Vose, Laura A Levit, Patricia Hurley, Carrie Lee, Michael A Thompson, Teresa Stewart, Janie Hofacker, Suanna S Bruinooge, and Daniel F Hayes (Article)

An online tool to assess the quality of research programs, Renee Yvonne Smith, Patricia A. Hurley, Michael A. Thompson, Dax Kurbegov, and Nicholas J. Robert (Abstract)

PDF

A Pilot Study of Circulating Tumor Cells in Stage IV Non-Small Cell Lung Carcinoma, Max Haid, Edward Chesna, Mary Theodoroff, Debra K. Spaeth, Cheruppolil R. Santhosh-Kumar, and Zahid N. Dar (Original Research)

Bell’s palsy as the initial presentation of multiple myeloma: A case report, Qiaofang Chen, Carol Huibregtse, and Cheruppolil R. Santhosh-Kumar (Case Report)

Breast cancer diagnosed by stress SPECT sestamibi: The role of inverse gray-scale imaging, Khawaja Afzal Ammar, Armaan Shaikh, Michael Anigbogu, and Steven C. Port (Article)

Challenges with research contract negotiations in community-based cancer research, Michael A. Thompson, Patricia A Hurley, Bryan Faller, Jean Longinette, Katie Richter, Teresa L Stewart, and Nicholas Robert (Article)

Connect MDS/AML: design of the myelodysplastic syndromes and acute myeloid leukemia disease registry, a prospective observational cohort study, David P Steensma, Medrdad Abedi, Rafael Bejar, Christopher R Cogle, Kathryn Foucar, Guillermo Garcia-Manero, Tracy I George, David Grinblatt, Rami Komrokji, Xiaomei Ma, Jaroslaw Maciejewski, Daniel A Pollyea, Michael R Savona, Bart Scott, Mikkael A Sekeres, Michael A. Thompson, Arlene S Swern, Melissa Nifenecker, Mary M Sugrue, and Harry Erba (Article)

Current diagnosis patterns for acute myeloid leukemia (AML) in clinical practice compared with World Health Organization (WHO) 2008 recommendations: outcomes from the CONNECT® Myelodysplastic Syndromes (MDS) and AML disease registry, Tracy I. George, Harry P. Erba, David P. Steensma, Daniel A. Pollyea, Mehrdad Abedi, Rafael Bejar, Christopher R. Cogle, Guillermo Garcia-Manero, David L. Grinblatt, Rami S. Komrokji, Jaroslaw P. Maciejewski, Dennis Revicki, Gail J. Roboz, Michael R. Savona, Bart L. Scott, Mikkael A. Sekeres, Michael A. Thompson, Albert Fliss, Arlene S. Swern, Melissa Nifenecker, Pavel Kiselev, Mary M. Sugrue, and Kathryn Foucar (Abstract)

PDF

Determining the Incidence and Factors of Cardiotoxicity in Breast Cancer Patients Treated With Anthracycline and/or Trastuzumab-Containing Regimen at Aurora Health Care, Stephanie Ghojallu, Matthew Rappelt, Han-Yang Chen, Ruth Perez, Lydia Garlie, Geoffrey Riddell, Yingying Gu, Jun Zhang, Rubina Qamar, Bijoy K. Khandheria, Arshad Jahangir, and Yang Shi (Supplement)

Dexamethasone alone and in combination with desipramine, phenytoin, valproic acid or levetiracetam interferes with 5-ALA-mediated PpIX production and cellular retention in glioblastoma cells, Johnathan E Lawrence, Christopher J Steele, Richard A Rovin, Robert J Belton, and Robert J Winn (Article)

Disease-specific hashtags for online communication about cancer care, Matthew S Katz, Audun Utengen, Patricia F Anderson, Michael A. Thompson, Deanna J Attai, Claire Johnston, and Don S Dizon (Article)

Effect on clinical trial participation by integration of a clinical pathway program into an electronic health record (EHR), Corey J. Shamah and Thomas J. Saphner (Abstract)

Engaging managing physicians in clinical staging prior to the initiation of cancer treatment, Anne Barry-Weers, Carol Huibregtse, Marija Bjegovich-Weidman, and James Weese (Abstract)

Erratum to: NK cell-mediated antibody-dependent cellular cytotoxicity is enhanced by tamoxifen in HER2/neu non-amplified, but not HER2/neu-amplified, breast cancer cells, John O Richards, Alex J. Albers, Thomas S. Smith, and Judy A. Tjoe MD (Article)

Extradigital glomus tumor: a rare etiology for wrist soft tissue mass, Justin E. Friske, Vipul Sharma, S A. Kolpin, and Nicholas Webber (Case Report)

Global, prospective, non-interventional, observational study of presentation, treatment patterns, and outcomes in multiple myeloma patients: the Insight-MM Study, Robert M. Rifkin, Faith E. Davies, Antonio Palumbo, Jeffrey Zonder, Saulius K. Girnius, Caitlin L. Costello, Saad Z. Usmani, Jesus G. Berdeja, Jim Omel, Michael A. Thompson, Jatin Shah, J Sanford Schwartz, Roman Hajek, Evangelos Terpos, Vânia Hungria, Maria-Victoria Mateos, Gordon Cook, Xavier Leleu, Andrew Spencer, Hartmut Goldschmidt, Brian Seal, Chris L. Pashos, Dawn Marie Stull, Dorothy Romanus, Roxanne Cacioppo, Jill A. Bell, Shawn Yu, Katarina Luptakova, Liviu Niculescu, Stephen J. Noga, Tomas Skacel, and Ajai Chari (Abstract)

Implementation of treatment pathways in a large integrated health care system, James Leighton Weese, Levi Citrin, Corey J. Shamah, and Marija Bjegovich-Weidman (Abstract)

Implementing survivorship care planning in a large integrated cancer program, M. Jamie Cairo, Carol Huibregtse, Adam Ferry, and James Weese (Abstract)

Insights from building a new National Cancer Institute Community Oncology Research Network Program site, Thomas J. Saphner, Michael A. Thompson, Sara Planton, Maharaj Singh, Neha Glandt, Lisa Robinson, and Jan DeBartolo (Article)

Integration of a clinical pathways software into an EHR in a large, multisite, hospital-affiliated community oncology setting, Corey J. Shamah, Thomas J. Saphner, Jacob C. Frick, Carol Huibregtse, and Gail Stiemke (Abstract)

Measures of appropriateness and value for breast surgeons and their patients: the american society of breast surgeons choosing wisely (®) initiative, Jeffrey Landercasper, Lisa Bailey, Tiffany S Berry, Robert R Buras, Amy C Degnim, Oluwadamilola M Fayanju, Joshua Froman, Jennifer Gass, Caprice Greenberg, Starr Koslow Mautner, Helen Krontiras, Roshni Rao, Michelle Sowden, Judy A. Tjoe, Barbara Wexelman, Lee Wilke, and Steven L Chen (Article)

Metastatic bone disease: femur—tibia, Nicholas Webber (Book Chapter)

PDF

MGMT inhibition by disulfiram sensitizes ER+ breast cancer cells to temozolomide and cyclophosphamide, Santhi Konduri, Deborah Donohoe, Alisher Holmuhamednov, Tarun Jella, and George C. Bobustuc (Poster)

Multiple myeloma vaccination sequential immune response pilot study, Michael A. Thompson, Martin K. Oaks, John O Richards, Maharaj Singh, Thomas S S. Smith, Karen M. Michel, Andinet W. Alemu, Michael P. Mullane, Husam S. Tarawneh, Angela M. Kraut, Kayla J. Hamm, and Carla Fuentes (Abstract)

New insights into estrogenic regulation of O(6)-methylguanine DNA-methyltransferase (MGMT) in human breast cancer cells: Co-degradation of ER-α and MGMT proteins by fulvestrant or O(6)-benzylguanine indicates fresh avenues for therapy, Ameya Paranjpe, Nathan I Bailey, Santhi Konduri, George C. Bobustuc, Francis Ali-Osman, Mohd A Yusuf, Surendra R Punganuru, Hanumantha Rao Madala, Debasish Basak, Agm Mostofa, and Kalkunte S Srivenugopal (Article)

New primary palliative care (PC) model for community cancer clinics (CCC), Cheruppolil R. Santhosh-Kumar, Deborah Gray, Stephanie Struve, Carol Huibregtse, and Qiaofang Chen (Abstract)

NK cell-mediated antibody-dependent cellular cytotoxicity is enhanced by tamoxifen in HER2/neu non-amplified, but not HER2/neu-amplified, breast cancer cells, John O Richards, Alex J. Albers, Thomas S Smith, and Judy A. Tjoe (Article)

Risk factors of trastuzumab-induced cardiotoxicity in breast cancer: A meta-analysis, Zeeshan Jawa, Ruth M Perez, Lydia Garlie, Maharaj Singh, Rubina Qamar, Bijoy K Khandheria, Arshad Jahangir, and Yang Shi (Article)

Selective omission of level V nodal coverage for patients with oropharyngeal cancer: Clinical validation of intensity-modulated radiotherapy experience and dosimetric significance, Pranshu Mohindra, Erich Urban, Jonathan D Pagan, Heather M Geye, Vatsal B Patel, R Adam A Bayliss, Edward T Bender, and Paul M Harari (Article)

Social media and internet resources for patients with blastic plasmacytoid dendritic cell neoplasm (bpdcn), Naveen Pemmaraju, Vikas Gupta, Michael A. Thompson, and Andrew A. Lane (Article)

Social media and myeloproliferative neoplasms (mpn): analysis of advanced metrics from the first year of a new twitter community: #mpnsm, Naveen Pemmaraju, Audun Utengen, Vikas Gupta, Jean-Jacques Kiladjian, Ruben Mesa, and Michael A. Thompson (Article)

Social media in cancer care: highlights, challenges & opportunities, Deanna J Attai, Mina S Sedrak, Matthew S Katz, Michael A. Thompson, Patricia F Anderson, Jennifer C Kesselheim, Michael J Fisch, David L Graham, Audun Utengen, Claire Johnston, Robert S Miller, and Don S Dizon (Article)

Social media in cancer care: highlights, challenges & opportunities, Deanna J Attai, Mina S Sedrak, Matthew S Katz, Michael A. Thompson, Patricia F Anderson, Jennifer C Kesselheim, Michael J Fisch, David L Graham, Audun Utengen, Claire Johnston, Robert S Miller, and Don S Dizon (Article)

Survivors speak: a qualitative analysis of motivational factors influencing breast cancer survivors' participation in a sprint distance triathlon, Karen M Robinson, Linda B Piacentine, Leslie J. Waltke, Alexander V Ng, and Judy A. Tjoe (Article)

Targeting Estrogen Receptor Beta in a Phase 2 Study of High-Dose Estradiol in Metastatic Triple-Negative Breast Cancer: A Wisconsin Oncology Network Study, Kari B Wisinski, Wei Xu, Amye J Tevaarwerk, Sandeep Saha, KyungMann Kim, Anne Traynor, Leah Dietrich, Robert Hegeman, Dhimant Patel, Jules Blank, Josephine Harter, and Mark E Burkard (Article)

The impact of perioperative β blocker use on patient outcomes after primary cytoreductive surgery in high-grade epithelial ovarian carcinoma, Ahmed Al-Niaimi, Elizabeth L. Dickson, Cassandra Albertin, Jennifer Karnowski, Cassandra Niemi, Ryan Spencer, Mian M K Shahzad, Shitanshu Uppal, Sandeep Saha, Laurel Rice, and Amy Mc Nally (Article)

The role of surgical primary tumor extirpation in de novo stage IV breast cancer in the era of targeted treatment, Judy A. Tjoe, Danielle M. Greer, and Ahmed Dalmar (Abstract)

Tumor diameter as a predictor of lymphatic dissemination in endometrioid endometrial cancer, Callie Cox Bauer, Danielle M. Greer, Jessica J. F. Kram, and Scott A. Kamelle (Article)

PDF

Understanding Health Care Costs in a Wisconsin Acute Leukemia Population, Patricia Steinert and Ron A. Cisler (Original Research)

Works from 2015

American Society of Clinical Oncology policy statement update: the critical role of phase I trials in cancer research and treatment, Jeffrey S Weber, Laura A Levit, Peter C Adamson, Suanna Bruinooge, Howard A Burris, Michael A Carducci, Adam P Dicker, Mithat Gönen, Stephen M Keefe, Michael A Postow, Michael A. Thompson, David M Waterhouse, Susan L Weiner, and Lynn M Schuchter (Article)

PDF

A Meta-Analysis of Incidence and Risk Factors of Trastuzumab-Induced Cardiotoxicity in Breast Cancer, Zeeshan Ali Jawa, Ruth M. Perez, Lydia Garlie, Maharaj Singh, Rubina Qamar, Bijoy K. Khandheria, Arshad Jahangir, and Yang Shi (Supplement)

A phase 2 study of weekly temsirolimus and bortezomib for relapsed or refractory B-cell non-Hodgkin lymphoma: A Wisconsin Oncology Network study, Timothy S Fenske, Namrata M Shah, Kyung Mann Kim, Sandeep Saha, Chong Zhang, Arielle E Baim, John P Farnen, Adedayo A Onitilo, Jules H Blank, Harish Ahuja, Tim Wassenaar, Rubina Qamar, Patrick Mansky, Anne M Traynor, and Ryan J Mattison (Article)

PDF

Breast Cancer Screening: Early Detection Is Not Enough, Judy A. Tjoe (Editorial)

Disease-Specific Hashtags for Online Communication About Cancer Care, Matthew S Katz, Audun Utengen, Patricia F Anderson, Michael A. Thompson, Deanna J Attai, Claire Johnston, and Don S Dizon (Article)

PDF

Does the Expression of Ki-67, p16 and COX-2 at Initial Diagnosis of Breast Atypia or Usual Ductal Hyperplasia Predict a Second Clinically Significant Event?, Judy A. Tjoe, Philippe Gascard, Jianxin Zhao, Gary F. Neitzel, Maharaj Singh, Brittany Last, James Marx, Thea Tlsty, and Sanjay Kansra (Supplement)

‘Everyone is an individual’: providing individualized treatment in oncology, Michael A. Thompson (Article)

Hepatology: Complete regression of locally advanced hepatocellular carcinoma following Sorafenib monotherapy, Shiva Kumar (Article)

Improving quality metric adherence to minimally invasive breast biopsy among surgeons within a multihospital health care system, Judy A. Tjoe, Danielle M. Greer, Sue Ihde, Diane A Bares, Wendy M Mikkelson, and James Weese (Article)

Incidence of cutaneous malignant melanoma by socioeconomic status in Canada: 1992-2006, Stephanie E Johnson-Obaseki, Varant Labajian, Martin Corsten, and James T McDonald (Article)

Incidence of differentiated thyroid cancer in Canada by City of residence, Martin Corsten, Matthew Hearn, James Ted McDonald, and Stephanie Johnson-Obaseki (Article)

In support of a patient-driven initiative and petition to lower the high price of cancer drugs, A Tefferi, H Kantarjian, S V. Rajkumar, and Michael A. Thompson (Article)

Integrated molecular pathology accurately determines the malignant potential of pancreatic cysts, MA Al-Haddad, T Kowalski, A Siddiqui, H R. Mertz, D Mallat, N Haddad, N Malhotra, B Sadowski, M J. Lybik, Marc F Catalano, S N. Okoh, L Rosenkranz, M Karasik, M Golioto, J Linder, and S N. Patel (Article)

PDF

In Vitro Growth Suppression of Renal Carcinoma Cells by Curcumin, Santhi Konduri, Madhavi Latha Yadav Bangaru, Phu Thanh Do, Shenglin Chen, Jeffrey Woodliff, and Sanjay Kansra (Supplement)